GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (XTER:BAYN) » Definitions » Valuation Rank

Bayer AG (XTER:BAYN) Valuation Rank


View and export this data going back to 1953. Start your Free Trial

What is Bayer AG Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Bayer AG Valuation Rank Related Terms

Thank you for viewing the detailed overview of Bayer AG's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Bayer AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (XTER:BAYN) » Definitions » Valuation Rank
Comparable Companies
INFU STAA LMAT COO ZJYL MMSI WST AVTR STVN ALGN LLY OCSE:NOVO B JNJ ABBV MRK XSWX:ROG XSWX:NOVN LSE:AZN AMGN PFE
Traded in Other Exchanges
BAYZF:USA BAYRY:USA BAYN:Romania BAY:Poland 1BAYN:Italy BAYER:Hungary 0P6S:UK BAYNd:UK BAYN:Bulgaria BAYN:Austria
Address
Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Website
https://www.bayer.com
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.